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Abstract
Human and guinea pig fetuses are completely dependent on an adequate maternal vitamin C (vitC) intake. Shortage of micronutrients can
have negative implications for fetal health and pregnancy outcome; however, knowledge of maternal vitC deficiency’s impact on fetal
development is sparse and reports of pregnancy outcome have been divergent. The present study investigated whether maternal vitC
deficiency affects pregnancy outcome and plasma vitC distribution between the mother and the offspring in a guinea pig model. A total
of eighty pregnant Dunkin Hartley guinea pigs were randomised into two weight-stratified groups receiving either a deficient (100 mg/kg
DEF) or a control (923 mg/kg CTRL) diet. VitC levels were measured in plasma during pregnancy and postpartum, and in the plasma and
brain of newborns. Pregnancy outcome was recorded with respect to birth weight and perinatal survival and were similar between groups.
Plasma vitC in dams declined throughout gestation in both groups (P,0·01). Compared with maternal plasma vitC, plasma vitC of new-
born pups was found to be significantly lower in the DEF group (P,0·001) and higher in the CTRL group (P,0·001), respectively. Brain
vitC levels were significantly reduced in DEF newborn pups (P,0·001). The present results indicate that preferential transport of vitC from
the mother to the fetus is overridden during sustained maternal vitC deficiency, maintaining maternal vitC concentration at the expense of
the offspring. This contradicts the notion that a fetus is protected from vitC deficiency by the placental Na-dependent vitC co-transporter,
SVCT2, thus fetal development may be susceptible to the negative effects of maternal vitC deficiency.
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Malnutrition during fetal development and infancy – e.g. DHA,
Fe and folic acid deficiencies(1–5) – can have severe negative
implications for the brain and nervous system and may also
affect the outcome of pregnancy, leading to premature births
and the birth of weak or stillborn offspring(6,7). We have
hypothesised that vitamin C (vitC) is a pivotal factor in
normal brain development(8), and have recently reported that
prenatal vitC deficiency leads to persistent postnatal hippocam-
pal volume reduction and impaired neuronal migration(9).
Moreover, we have shown that postnatal vitC deficiency has
detrimental effects on hippocampal neuron number and func-
tion(10), and that severe postnatal vitC depletion in weanling
guinea pigs leads to oxidative stress in the brain(11). In mice,
a functional vitC transport (mediated by the Na-dependent
vitC co-transporter 2; SVCT2) has been shown to be essential
for perinatal survival(12). However, knowledge of vitC defi-
ciency’s impact on in utero fetal development remains sparse.
Due to a mutation in the gene encoding for L-gulonolactone
oxidase required for ascorbate synthesis, humans and guinea
pigs are dependent on a dietary vitC source(13). Consequently,
fetal supply of vitC relies on an adequate maternal dietary
intake(14) and, expectedly, the maternal:fetal transport ratio
has been shown to be dependent on maternal vitC
status(15–17). In humans, vitC in plasma shows a declining
maternal plasma concentration during pregnancy(15), while
vitC levels in newborns are typically higher than those in
their post-parturient mothers(16,17). This is most probably
due to an active placental transport of ascorbate as indicated
in both in vitro and in vivo studies(12,18,19). As with humans,
the guinea pig has a haemochorial placenta and is a validated
animal model for placental transfer(20–22). This makes the
guinea pig a rational model for studying the putative effects
of dietary-imposed chronic vitC deficiency on pregnancy
outcome.
In humans, a daily intake of 200–400 mg vitC for adults
results in plasma concentrations of about 70mmol/l(23,24), at
which point tissue saturation is achieved. However, vitC
deficiency (hypovitaminosis C) defined as a plasma concen-
tration ,23mmol/l and severe vitC deficiency (a plasma con-
centration ,11mmol/l)(25) remains surprisingly common.
*Corresponding author: Professor J. Lykkesfeldt, fax þ45 353 53514, email jopl@sund.ku.dk
Abbreviations: CTRL, control group; DEF, deficient group; SVCT2, sodium-dependent vitamin C co-transporter 2; vitC, vitamin C.
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Even in the developed world, large cross-sectional studies
have found that vitC deficiency affects between 7 and 40 %
of the population, with high-risk subpopulations such as
pregnant women, children and smokers being most vulner-
able(17,26–28). In spite of this high prevalence of vitC
deficiency, its potential impact on pregnancy and newborns
has only been the subject of little attention.
Using guinea pigs as an in vivo model, the present study
investigated the impact of a prolonged subclinical maternal
vitC deficiency during the second and third trimesters on
maternal and early postnatal vitC status, birth weight and peri-
natal survival in guinea pig offspring.
Materials and methods
In vivo study
The study was approved by the Danish Animal Experimen-
tation Inspectorate. Upon arrival, a total of eighty time-
mated Dunkin Hartley guinea pigs (Charles River
Laboratories), second-time breeders at gestational day 18,
were weighed and tagged with a 12 mm microchip subcu-
taneously in the neck for identification (Pet-Id; Danworth
Farm). The animals were randomly assigned to one of two
weight-stratified groups that received special quality-con-
trolled diets (Special Diets Services) either sufficient in vitC
(923 mg/kg by analysis; product code: 829427-B#32 786; con-
trol (CTRL) group, n 30) or deficient in vitC (100 mg/kg by
analysis; product code: 829415-B#32 785; deficient (DEF)
group, n 50). The diets were produced to meet the nutritional
requirements of guinea pigs and were identical in all aspects
except vitC content. We have previously shown that a dose
of 100 mg vitC/kg induces a non-scorbutic vitC deficiency in
guinea pigs(29,30). Accordingly, none of the animals exhibited
any clinical signs of scurvy during the study. The groups
were allowed ad libitum feeding, dried hay (tested negative
for vitC content) and drinking water. They were housed in
large floor pens with a 12 h light cycle and tended several
times daily by trained staff. All newborn pups (live: n 285,
dead: n 58) were recorded within a maximum of 24 h from
birth and viable pups were weighed, marked for identification
and their sex determined.
Dams and pups were weighed once and twice weekly,
respectively, and eight dams from each group (each time ran-
domly chosen by a computer) were assigned for the collection
of blood samples at arrival (ultimo first trimester, gestational
day 18) and at the beginning of the third trimester (gestational
day 40). Blood samples were collected from the saphenous
vein on its superficial course on the tibia (300ml). Only one
pregnant female from the CTRL group died due to pregnancy
toxaemia and five animals proved not to have conceived.
Euthanasia
At postnatal days 2–7 (pups) and postpartum days 7–10
(dams), four groups of newborn pups (n 10–11; females/
males; CTRL/DEF) and two groups of dams (n 5–10;
CTRL/DEF) were anaesthetised with inhalation of isoflurane
(Isoba Vet 100 %; Intervet International), and blood (4 ml)
was gently collected by cardiac puncture with an 18G hypo-
dermic needle in a 5 ml syringe previously flushed with 15 %
tripotassium-EDTA(31). Subsequently, while still anaesthetised,
the animals were euthanised by exsanguination and decapi-
tation. Plasma from dams and female/male pups and brains
from female pups (either the right or left hemisphere,
randomly assigned by a computer and divided by section
through the cerebral longitudinal fissure) were immediately
frozen at 2808C until biochemical analyses were performed.
The remaining brain tissues, pups and postpartum dams
were allocated to other studies.
Biochemical analyses
Analysis of ascorbate and dehydroascorbic acid in a meta-
phosphoric acid-stabilised plasma and brain homogenate was
performed at HPLC with coulometric detection as described
previously(32,33). As a measure of ascorbate oxidation, the
ascorbate oxidation ratio in the brain was calculated as a
percentage of dehydroascorbic acid of total vitC. Glutathione
was measured spectrofluorometrically according to the
method by Hissin & Hilf(34) modified for microtitre plates.
Lipid oxidation was assessed by measuring malondialdehyde
as described previously(35) and 8-F2-isoprostanes as described
by the assay kit manufacturer (catalogue no. 516351; Cayman
Chemicals).
Statistical analysis
Differences in body weight and plasma concentrations of
ascorbic acid were evaluated by one-way ANOVA followed
by Tukey’s multiple comparison test to describe differences
in means. In the case of a non-Gaussian distribution as estab-
lished by the D’Agostino and Pearson omnibus normality test,
evaluation was conducted by the Kruskal–Wallis test followed
by Dunn’s multiple comparisons. Data were analysed using
Statistica (Statsoft). To assess the differences in perinatal mor-
tality, logistic regression analysis corrected for overdispersion
was carried out in SAS version 9.2 (SAS Institute, Inc.). The sig-
nificance level for all statistical analyses was P,0·05 and data
are expressed as means and standard deviations unless other-
wise stated.
Results
Maternal weight gain and birth weight
No signs of pregnancy-associated disease or dystocia were
recorded for dams brought to term. Maternal weight gain
during gestation was similar between the groups (Fig. 1).
Due to group housing in large pens, individual litter sizes
could not be recorded and because of a few incidences of can-
nibalism, the recorded number of perinatally dead pups could
be slightly flawed. There was no significant difference in the
birth weight of live-born pups between the groups (CTRL
80·0 (SD 18·1) g v. DEF 80·7 (SD 15·9) g) or sex (females
80·06 (SD 16·59) g v. males 80·97 (SD 16·91) g).
J. G. Schjoldager et al.1574
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Plasma levels of total vitamin C concentration
Upon arrival at gestational day 18, dams displayed plasma
levels of total vitC of 39·8 (SD 11·8)mmol/l. As expected, the
dietary regimen was reflected in the plasma levels of total
vitC, CTRL dams had significantly higher plasma vitC levels
than DEF dams at both gestational day 40 (CTRL: 36·3
(SD 6·8) v. DEF: 3·9 (SD 1·2)mmol/l) and at postpartum days
7–10 (CTRL: 21·8 (SD 9·0) v. DEF: 3·1 (SD 2·0)mmol/l), as dis-
played in Fig. 2. Towards parturition, vitC status in the CTRL
dams declined significantly (P,0·01; Fig. 2). In the DEF
dams, plasma vitC levels declined significantly within
3 weeks after arrival (to 3·9 (SD 1·2)mmol/l) and remained at
this low level during pregnancy and parturition (P,0·001;
Fig. 2). The dietary regimen was also reflected in plasma
vitC concentrations of newborn pups. However, as no effect
of sex on vitC concentration could be detected in either group
of newborns, vitC data from both sexes were pooled within
the groups. The newborn CTRL pups had significantly higher
plasma vitC concentrations (CTRL pups: 66·3 (SD 27·4)mmol/l)
compared with the CTRL dams at parturition (P,0·001;
Fig. 3(a)); however, in contrast, the newborn DEF pups had a
significantly lower plasma level of vitC (1·6 (SD 0·7)mmol/l)
compared with their mothers (P,0·001; Fig. 3(b)).
Oxidative stress markers in the brain
In the newborn DEF female pups, vitC concentrations in the
brain decreased by 60 % as a result of the maternal dietary
regimen (P,0·001; Table 1). No effects on the measured oxi-
dative stress and damage markers, i.e. ascorbate oxidation
ratio, glutathione, malondialdehyde or 8-F2-isoprostanes,
were found in the brain (Table 1).
Perinatal survival
A total of 143 CTRL (n 29 dams) and 200 DEF (n 45 dams)
pups were delivered. Of these, eighteen CTRL and forty DEF
pups were recorded as dead perinatally (i.e. dead in utero
or within a maximum of 24 h after birth). All dead pups
appeared to be delivered at or very close to term. No macro-
scopic causes of death could be identified, except from one
mummified fetus (DEF) and five moribund newborns (DEF)
that were immediately euthanised by cervical dislocation. To
evaluate the association between the maternal diet and the off-
spring’s risk of perinatal death, data were fitted to a logistic
regression model corrected for overdispersion between day
and diet. When corrected for overdispersion, the effect of
diet was not significant (P¼0·18) with an OR for perinatal
death being (DEF v. CTRL) 1·7 (95 % CI 0·8, 23·9).
Discussion
In both humans and guinea pigs, maternal vitC intake affects
vitC concentrations in offspring(36–39). During gestation,
maternal plasma levels decline even when maternal vitC
intake is high(15). In agreement, the present study also reports
of a declining maternal vitC concentration in both investigated
dietary groups during gestation. Interestingly, DEF pups were
significantly lower in vitC than DEF dams at gestational day 40,
i.e. during the third trimester.
It has been proposed that the placental–fetal consolidation
is genetically programmed to alter maternal physiology to
benefit the fetus and to ensure survival until birth, sometimes
at the expense of the mother(40). Conditions such as gesta-
tional hypertension and pre-eclampsia have been suggested
to develop when the mother is unable to meet fetal nutritional
requirements(40) and in cases of insufficient Ca, fetal supply
is ensured by maternal release from the bone, ultimately
decreasing maternal skeletal strength(41). In humans, an insuf-
ficient maternal vitC intake, defined from maternal blood
samples taken at parturition or dietary information provided
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Fig. 1. Maternal weight gain during gestation. Body weights were recorded
once weekly. Data are shown as weight gain normalised to body weight on
arrival. Data are presented using body-weight gestational day 18 as baseline.
Values are means, with their standard errors represented by vertical bars.
There was no significant difference between the deficient ( , n 45) and con-
trol ( , n 29) dams at any of the recorded time points.
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Fig. 2. Plasma vitamin C (vitC) levels in dams. Initial vitC levels were
recorded upon arrival at gestational day (GD) 18. On both GD 40 and post-
partum day (PP) 7, plasma vitC levels in the deficient (DEF) dams were sig-
nificantly lower compared with the control (CTRL) dams (***P,0·001),
reflecting the two applied dietary regimens. Also, plasma vitC levels in the
CTRL dams declined significantly during gestation (**P,0·01). Data are
obtained from randomly chosen pregnant/postpartum dams (n 5–10;
CTRL/DEF) at each time point. Values are means, with standard deviations
represented by vertical bars.
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by pregnant women, has been reported to increase fetal:
maternal plasma vitC ratios (i.e. fetal levels increase and
maternal levels decrease) even under conditions associated
with maternal deficiency(15,42). This has led to the proposal
of a selective retention of vitC by the placenta, ensuring ade-
quate fetal levels even during severe maternal deficiency.
However, it should be noted that the cited reports on maternal
vitC deficiency date back to the late 1930s and early 1940s,
where analytical methodology did not appropriately control
for post-sampling and storage-induced degradation of ascor-
bate. Considering the labile nature of vitC(33), there is reason
to believe that the authors may have significantly underesti-
mated the vitC content of the blood samples in the absence
of adequate technology. Moreover, the majority of the individ-
uals included were in fact not severely vitC deficient by
current definitions(25). Consequently, it remains to be investi-
gated to what extent the present data can be translated to
human pregnancies.
Recent data emphasise SVCT2 as the dominant contributor
to the placental transfer of vitC(12,18,19,43) and in vivo studies
in SVCT2(2 /2 ) mice have strongly suggested that placental
uptake of vitC requires functional SVCT2 transporters(43).
Thus, regulatory mechanisms associated with a preferential
transport across the placenta are most likely to be SVCT2-
mediated. The present findings suggest that maternal
deficiency during gestation may override such preferential
maternal transport, sustaining a basal maternal vitC concen-
tration preventing maternal scurvy at the expense of the
offspring.
Natural selection favouring short-term survival over long-
term health and reproduction through the allocation of
scarce micronutrients by triage is a known hypothesis(44)
and has been reported, for example, for vitamin K and
Se(45,46). Reports have stated that vitC concentrations in fetal
blood decrease towards birth(47,48) and up to 50 % perina-
tally(49–51); thus, postnatally obtained plasma samples might
differ from the prenatal level. However, mean vitC concen-
trations in newborn CTRL pups were 50-fold higher in
plasma and 3-fold higher in brain tissue compared with new-
born DEF pups, making comparable fetal vitC exposure
in utero highly unlikely.
VitC is well accepted to have a pivotal role as an antioxidant
and in the maintenance of redox homeostasis, and serves as a
cofactor in the formation and reuptake of neurotransmitters in
the brain(8). The developing brain is highly susceptible to oxi-
dative damage due to immaturity and decreased levels and
synthesis of antioxidant enzymes, high oxygen consumption
and readily oxidisable PUFA(52). Increased oxidative stress in
the brain has been shown in SVCT2(2 /2 ) mice delivered by
caesarian sections close to term(43) and in the offspring of
gulonolactone oxidase-knockout mice unable to synthesise
vitC(53); thus, it is conceivable that maternal vitC deficiency
leads to prenatal oxidative stress. In humans, oxidative stress
has been suggested to play a role in the pathogenesis of a
number of diseases in the pregnant mother and the new-
born(54), including intraventricular haemorrhage leading to
neonatal brain damage(55). Furthermore, oxidative stress has
been suggested as a plausible link between adverse fetal
development and pregnancy outcome and the risk of develop-
ing chronic diseases later in life(56). However, in the present
study, no differences in oxidative stress markers – apart
from vitC itself – were observed between the groups,
suggesting that vitC deficiency imposed on these animals did
not induce oxidative stress in the narrow time window studied
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Fig. 3. Plasma vitamin C (vitC) levels in dams and offspring. (a) Newborn
control (CTRL) female (n 10) and male (n 10) pups at postnatal day (P) 7
had significantly higher vitC levels than the CTRL dams at postpartum
day(PP) 7 (***P,0·001). P7 female and male data are pooled as no effect of
sex was observed. (b) Newborn deficient (DEF) female (n 11) and male (n
10) pups at postnatal day (P) 7 had significantly lower plasma vitC than the
DEF dams during gestation (***P,0·001). P7 female and male data are
pooled as no effect of sex was observed. Values are means, with standard
deviations represented by vertical bars.
Table 1. Antioxidant status and lipid oxidation markers in the brains of
newborn guinea pig pups
(Mean values and standard deviations)
Controls Deficient
Mean SD Mean SD
n 10 11
Vitamin C (nmol/g tissue) 1816 105 659*** 102
AOR (% oxidised of total vitC)† 4·0 3·6 6·3 4·7
Glutathione (nmol/g tissue) 1268 67 1330 90
Malondialdehyde (nmol/g tissue) 530 74 566 86
8-F2-isoprostanes (ng/g tissue) 8·1 1·1 8·2 1·4
AOR, ascorbate oxidation ratio; vitC, vitamin C.
***Mean value was significantly different compared with the control animals
(P,0·001; one-way ANOVA using Tukey’s post hoc test of planned compari-
sons).
†AOR is calculated as dehydroascorbic acid divided by total vitC in percentage.
J. G. Schjoldager et al.1576
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here (Table 1), although the brain levels of vitC in the DEF
newborns were decreased by approximately 60 % compared
with the CTRL group. This observation is in accordance
with previously obtained results(9,10) indicating that alterations
in redox homeostasis may not be the primary course
underlying the detrimental effects of vitC deficiency on brain
development(9,10).
Mice devoid of SVCT2 die immediately after birth, displaying
intraparenchymal brain haemorrhage emphasising an essential
role of vitC in sustaining perinatal survival and normal brain
development(12). This finding has been confirmed by Harrison
et al.(43); SVCT2(2 /2 ) newborns died shortly after birth; how-
ever, fewer SVCT2(2 /2 ) and SVCT2(þ /2 ) offspring (generated
from SVCT2(þ /2 ) stock) than expected were recorded at
delivery, indicating that a lack of vitC in utero contributes to
increased fetal mortality. This is suggested to be, at least in
part, due to an impairment of collagen IV synthesis leading
to fragile capillaries and a subsequent increased risk of intra-
cortical haemorrhages and subsequent death in utero or at
parturition(43).
In human subjects, a low maternal intake of vitC has been
associated with an increased risk of pregnancy-associated dis-
orders such as pre-eclampsia(57) and a variety of adverse preg-
nancy outcomes such as preterm delivery(58) and decreased
birth weight(59). To reduce the risk of such adverse outcomes,
intake of periconceptional multivitamins on a daily basis has
been suggested(60,61); however, other authors have failed to
establish a positive correlation between maternal vitC intake
and pregnancy outcome(62–66). Hence, whether supplemen-
tation should be offered on a regular basis during pregnancy
or rather in the case of potentially ‘risk’ pregnancies remains
controversial. Moreover, to evaluate the true effect of vitC
deficiency and supplementation, inclusion criteria and vitC
status must be well defined between groups which, in
human trials, have often been neglected, leading to inconclu-
sive and divergent data(67). Thus, as discussed above, there are
presently insufficient data to conclude whether maternal vitC
deficiency also leads to deficiency in the offspring of humans.
In conclusion, chronic maternal vitC intake during the
second and third trimesters does not significantly influence
pregnancy outcome with respect to gestational length,
maternal weight gain, birth weight and perinatal survival in
guinea pigs. However, the present data combined with pre-
viously reported results(12,43) suggest that an inadequate
maternal vitC intake during pregnancy may indeed pose a
risk to the fetus. The findings of reduced plasma vitC in new-
born DEF pups compared with their mothers indicate that pre-
ferential transport of vitC from the mother to the fetus is
overridden during a prolonged maternal vitC deficiency,
hereby maintaining a basal maternal vitC concentration at
the expense of the offspring. The present results contradict
the notion that a fetus is protected from vitC deficiency and
suggest that a prolonged maternal vitC deficiency may have
a detrimental effect on fetal brain development in utero.
Well-designed clinical studies of the impact of maternal vitC
deficiency on fetal development are therefore warranted.
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